Feeds › Ownership stakes (13D / 13G)
Ownership stakes (13D / 13G)
Investors who own more than 5% of a company, from activists (13D) to passive holders (13G).
About this data
- What it is
- An investor who owns more than 5% of a public company must say so. Investors who may try to influence the company, such as activists, file the longer Schedule 13D; passive holders file the shorter Schedule 13G.
- Who files it
- The investor, within days of crossing 5%, and again whenever the stake changes materially.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- 13G filings are far more common than 13D. A 13D usually means the investor intends to push for changes, so it tends to get more attention.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Filings per day, last 30 days
13D (activist) 13G (passive)
Latest ownership filings
Showing: ticker PED
| Filed | ScheduleBoth report a stake of more than 5%. A 13D is filed by investors who may try to influence the company, such as activists; a 13G by passive holders. | Company | Investor | Shares | % of shares | Filing |
|---|---|---|---|---|---|---|
| Oct 13, 2026 | SCHEDULE 13D/A (amended) | PED Pedevco Corp. | Simon G. Kukes | 4.54M | 34.2% | SCHEDULE 13D/A ↗ |
| Oct 13, 2026 | SCHEDULE 13D/A (amended) | PED Pedevco Corp. | SGK 2018 Revocable Trust | 4.14M | 31.1% | SCHEDULE 13D/A ↗ |
| Mar 3, 2026 | SCHEDULE 13D/A (amended) | PED Pedevco Corp. | Simon G. Kukes | 87.93M | 33.1% | SCHEDULE 13D/A ↗ |
| Mar 3, 2026 | SCHEDULE 13D/A (amended) | PED Pedevco Corp. | SGK 2018 Revocable Trust | 79.81M | 30.0% | SCHEDULE 13D/A ↗ |
| Mar 3, 2026 | SCHEDULE 13D/A (amended) | PED Pedevco Corp. | Edward Geiser | 137.23M | 51.6% | SCHEDULE 13D/A ↗ |
| Mar 3, 2026 | SCHEDULE 13D/A (amended) | PED Pedevco Corp. | Juniper Capital IV GP, L.P. | 33.82M | 12.7% | SCHEDULE 13D/A ↗ |
| Mar 3, 2026 | SCHEDULE 13D/A (amended) | PED Pedevco Corp. | Juniper North Peak Partners GP, L.P. | 6.07M | 2.3% | SCHEDULE 13D/A ↗ |
| Mar 3, 2026 | SCHEDULE 13D/A (amended) | PED Pedevco Corp. | Juniper Capital III GP, L.P. | 62.82M | 23.6% | SCHEDULE 13D/A ↗ |
| Mar 3, 2026 | SCHEDULE 13D/A (amended) | PED Pedevco Corp. | Juniper Capital II GP, L.P. | 34.52M | 13.0% | SCHEDULE 13D/A ↗ |
| Nov 10, 2025 | SCHEDULE 13D/A (amended) | PED Pedevco Corp. | Simon G. Kukes | 59.94M | 64.8% | SCHEDULE 13D/A ↗ |
| Nov 10, 2025 | SCHEDULE 13D/A (amended) | PED Pedevco Corp. | SGK 2018 Revocable Trust | 51.79M | 56.0% | SCHEDULE 13D/A ↗ |
| Nov 7, 2025 | SCHEDULE 13D | PED Pedevco Corp. | Edward Geiser | 140.23M | 53.4% | SCHEDULE 13D ↗ |
| Nov 7, 2025 | SCHEDULE 13D | PED Pedevco Corp. | Juniper Capital IV GP, L.P. | 33.73M | 12.8% | SCHEDULE 13D ↗ |
| Nov 7, 2025 | SCHEDULE 13D | PED Pedevco Corp. | Juniper North Peak Partners GP, L.P. | 6.05M | 2.3% | SCHEDULE 13D ↗ |
| Nov 7, 2025 | SCHEDULE 13D | PED Pedevco Corp. | Juniper Capital III GP, L.P. | 62.79M | 23.9% | SCHEDULE 13D ↗ |
| Nov 7, 2025 | SCHEDULE 13D | PED Pedevco Corp. | Juniper Capital II GP, L.P. | 37.66M | 14.3% | SCHEDULE 13D ↗ |
| Jan 27, 2025 | SCHEDULE 13D | PED Pedevco Corp. | Simon G. Kukes | 59.74M | 65.4% | SCHEDULE 13D ↗ |
| Jan 27, 2025 | SCHEDULE 13D | PED Pedevco Corp. | SGK 2018 Revocable Trust | 51.79M | 56.7% | SCHEDULE 13D ↗ |
18 items, most recent first (up to 50). Every row links to its original filing. Updated Nov 15, 2026, 6:46 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances